Company registration number 12227547 (England and Wales)
CAMBRIDGE VASCULAR SERVICES LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024
PAGES FOR FILING WITH REGISTRAR
CAMBRIDGE VASCULAR SERVICES LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
CAMBRIDGE VASCULAR SERVICES LTD
BALANCE SHEET
AS AT 30 SEPTEMBER 2024
30 September 2024
- 1 -
2024
2023
Notes
£
£
£
£
Current assets
Debtors
3
28,606
26,787
Cash at bank and in hand
177,923
128,613
206,529
155,400
Creditors: amounts falling due within one year
4
(23,378)
(29,304)
Net current assets
183,151
126,096
Capital and reserves
Called up share capital
5
120
120
Profit and loss reserves
183,031
125,976
Total equity
183,151
126,096

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 26 June 2025
Dr M Gohel
Director
Company Registration No. 12227547
CAMBRIDGE VASCULAR SERVICES LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 2 -
1
Accounting policies
Company information

Cambridge Vascular Services Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Greenwood House, Greenwood Court, Skyliner Way, Bury St Edmunds, Suffolk, IP32 7GY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

1.2
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

CAMBRIDGE VASCULAR SERVICES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
1
Accounting policies
(Continued)
- 3 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
1
1
3
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
18,403
14,415
Other debtors
10,203
12,372
28,606
26,787

Included within other debtors due within 1 year is a loan to the Directors amounting to £10,203 (2023 - £12,372). Interest is charged at the official rate of interest. The balance was cleared within 9 months of the year end.

CAMBRIDGE VASCULAR SERVICES LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 4 -
4
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
2,280
-
0
Taxation and social security
15,604
23,085
Other creditors
5,494
6,219
23,378
29,304
5
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A Shares of £1 each
100
100
100
100
Ordinary B Shares of £1 each
10
10
10
10
Ordinary C Shares of £1 each
10
10
10
10
120
120
120
120
2024-09-302023-10-01falsefalsefalse26 June 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityDr M Gohel122275472023-10-012024-09-30122275472024-09-30122275472023-09-3012227547core:CurrentFinancialInstrumentscore:WithinOneYear2024-09-3012227547core:CurrentFinancialInstrumentscore:WithinOneYear2023-09-3012227547core:CurrentFinancialInstruments2024-09-3012227547core:CurrentFinancialInstruments2023-09-3012227547core:ShareCapital2024-09-3012227547core:ShareCapital2023-09-3012227547core:RetainedEarningsAccumulatedLosses2024-09-3012227547core:RetainedEarningsAccumulatedLosses2023-09-3012227547core:ShareCapitalOrdinaryShareClass12024-09-3012227547core:ShareCapitalOrdinaryShareClass12023-09-3012227547core:ShareCapitalOrdinaryShareClass22024-09-3012227547core:ShareCapitalOrdinaryShareClass22023-09-3012227547core:ShareCapitalOrdinaryShareClass32024-09-3012227547core:ShareCapitalOrdinaryShareClass32023-09-3012227547core:ShareCapitalOrdinaryShares2024-09-3012227547core:ShareCapitalOrdinaryShares2023-09-3012227547bus:Director12023-10-012024-09-30122275472022-10-012023-09-3012227547core:WithinOneYear2024-09-3012227547core:WithinOneYear2023-09-3012227547bus:OrdinaryShareClass12023-10-012024-09-3012227547bus:OrdinaryShareClass22023-10-012024-09-3012227547bus:OrdinaryShareClass32023-10-012024-09-3012227547bus:OrdinaryShareClass12024-09-3012227547bus:OrdinaryShareClass12023-09-3012227547bus:OrdinaryShareClass22024-09-3012227547bus:OrdinaryShareClass22023-09-3012227547bus:OrdinaryShareClass32024-09-3012227547bus:OrdinaryShareClass32023-09-3012227547bus:AllOrdinaryShares2024-09-3012227547bus:AllOrdinaryShares2023-09-3012227547bus:PrivateLimitedCompanyLtd2023-10-012024-09-3012227547bus:SmallCompaniesRegimeForAccounts2023-10-012024-09-3012227547bus:FRS1022023-10-012024-09-3012227547bus:AuditExemptWithAccountantsReport2023-10-012024-09-3012227547bus:FullAccounts2023-10-012024-09-30xbrli:purexbrli:sharesiso4217:GBP